Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?

BACKGROUND: With COVID-19 vaccine roll-out ongoing in many countries globally, monitoring of breakthrough infections is of great importance. Antibodies persist in the blood after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Since COVID-19 vaccines induce immune response...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Hoogen, Lotus L., Smits, Gaby, van Hagen, Cheyenne C.E., Wong, Denise, Vos, Eric R.A., van Boven, Michiel, de Melker, Hester E., van Vliet, Jeffrey, Kuijer, Marjan, Woudstra, Linde, Wijmenga-Monsuur, Alienke J., GeurtsvanKessel, Corine H., Stoof, Susanne P., Reukers, Daphne, Wijsman, Lisa A., Meijer, Adam, Reusken, Chantal B.E.M., Rots, Nynke Y., van der Klis, Fiona R.M., van Binnendijk, Robert S., den Hartog, Gerco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904156/
https://www.ncbi.nlm.nih.gov/pubmed/35287986
http://dx.doi.org/10.1016/j.vaccine.2022.03.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904156/
https://www.ncbi.nlm.nih.gov/pubmed/35287986
http://dx.doi.org/10.1016/j.vaccine.2022.03.009

Ejemplares similares